The Efficacy of Combined Therapy of Regorafenib with Detoxicating and Stasis Softening Chinese Herbal Spleen Tonics in Mid-/Late-Stage Hepatocellular Carcinoma

Table 1

Baseline characteristics of patients with hepatocellular carcinoma (n = 120).

Characteristics	# of patients
Gender
Female	28
Male	92
Age, median, years (range)	48 (28–70)
HBV-positive	84 (70%)
HCV-positive	12 (10%)
Alcohol abuse	18 (15%)
ECOG-PS, ≤1	120 (100%)
Child-pugh score
5	56 (46.7%)
6	42 (35%)
7	15 (12.5%)
Vascular invasion	74 (62%)
Extrahepatic metastasis	36 (30%)
BCLC stage
B	18 (15%)
C	102 (85%)
AFP
<400 ng/mL	93 (77.5)
≥400 ng/mL	27 (22.5%)

Safety of regorafenib and combined therapy with DSS.